![](/img/cover-not-exists.png)
Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program)
F.D. Richard Hobbs, Gianfranco Gensini, G.B. John Mancini, Athanasios J. Manolis, Beverly Bauer, Steffen Böhler, Jacques Genest, Ross Feldman, Peter Harvey, Trond G. Jenssen, Michael Metcalfe, Pedro MVolume:
110
Year:
2006
Language:
english
DOI:
10.1016/j.ijcard.2005.10.017
File:
PDF, 242 KB
english, 2006